Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Essential Drugs Monitor No. 017 (1994). Partial edition
(1994) [French] [Spanish]
Abstract
EDM-17 Drug Promotion. Included HTML article: Ethical Criteria for Medicinal Drug Promotion. (HTML version)
Table of Contents
View the documentIntroduction
View the documentObjective
View the documentEthical criteria
View the documentApplicability and implementation of criteria
View the documentPromotion
View the documentAdvertising
View the documentMedical Representatives
View the documentFree samples of prescription drugs for promotional purposes
View the documentSymposia and other scientific meetings
View the documentPost-marketing scientific studies, surveillance and dissemination of information
View the documentPackaging and labelling
View the documentInformation for patients: package inserts, leaflets and booklets
View the documentPromotion of exported drugs
View the documentAppendix - Sample Drug Information Sheet
Open this folder and view contentsEDM-17 DRUG DISCUSSIONS AT THE 47TH WORLD HEALTH ASSEMBLY
Open this folder and view contentsRole of the Pharmacist
 

Essential Drugs Monitor No. 017 (1994). Partial edition

In view of the wide readership and distribution of the Essential Drugs Monitor we reprint below the full text of the WHO Ethical Criteria for Medicinal Drug Promotion.

Ethical Criteria for Medicinal Drug Promotion

World Health Organization, Geneva 1988

Resolution WHA41.17 adopted by the Forty-first World Health Assembly, 13 May 1988

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014